Lockheed Martin's $292B Backlog: A Buy Signal for Defense Investors
💡 Key Takeaway
Lockheed Martin's backlog surge, driven by high-margin missiles and lower-risk contracts, makes it an attractive buy for defense-focused investors.
The Backlog Boom: Quantity and Quality
Lockheed Martin's order backlog has skyrocketed from $194 billion at the start of the year to $292 billion in the third quarter. This isn't just a numbers game—the composition of the backlog is shifting toward higher-margin and lower-risk work, which is a big deal for future profitability.
The standout performer is the Missiles and Fire Control (MFC) segment, where backlog more than tripled from $46.7 billion to $142.5 billion. MFC carries a 13.8% operating margin, the highest among Lockheed's segments, so as this backlog converts to revenue, overall margins should improve.
A major driver was the PAC-3 missile defense contract, a seven-year deal worth up to $58.6 billion. PAC-3 is a mature, proven technology, meaning far less development risk compared to complex new programs that have plagued defense contractors with cost overruns.
Lockheed and the Department of Defense are also reshaping contracts to be more mutually beneficial. New terms include long durations, inflation escalators, upfront payments for expansion costs, and cancellation protections—reducing financial risk for Lockheed.
Despite these positives, execution risks remain, particularly around supply chain management. But the overall trend is clearly favorable.
What This Means for Me
Why Investors Should Care
For investors, the backlog growth is a leading indicator of future revenue and earnings. The shift toward MFC means Lockheed's profit margin should expand as this high-margin work ramps up, boosting earnings per share.
The improved contract terms reduce the risk of massive charges that have hit peers like Boeing and RTX. This lowers uncertainty and makes Lockheed's cash flows more predictable, which could support a higher valuation multiple over time.
At 22 times earnings and 18.6 times free cash flow for 2026, Lockheed isn't screaming cheap, but it's reasonable for a defense leader with improving prospects. The stock could re-rate higher as investors gain confidence in the backlog's quality.
Defense spending remains robust amid global tensions, and Lockheed's focus on mature technologies positions it well to capture demand without taking on excessive development risk. This makes it a relatively safe way to play defense.
Stock to Watch
| Stocks | Impact | Analysis | |
|---|---|---|---|
| LMT | Positive | Backlog surge with higher-margin mix and lower-risk contracts should drive earnings growth and reduce volatility. | |
| RTX | Neutral | As a peer defense contractor, RTX may benefit from similar contract improvements but faces its own execution challenges. | |
| BA | Neutral | Boeing's defense unit has struggled with fixed-price development programs; any shift to better terms could help, but issues remain. |
Source: The Motley Fool
Analysis generated by Bobby AI quantitative model, reviewed and edited by our research team. This is not financial advice. Always do your own research before making investment decisions.
Bobby Insight

Lockheed Martin is a buy for defense-focused investors, given its high-quality backlog and improved contract terms.
The backlog growth in high-margin MFC and reduced risk from mature technologies and better contracts should drive margin expansion and earnings growth. Valuation is reasonable, and the stock offers a solid risk-reward for long-term investors.
What This Means for Me

Read More
Northrop Grumman's Stealth Drone Snub: What It Means for NOC
Bearish Northrop Grumman's loss of the CCA hardware contract is a setback, but its self-funded Talon Blue drone and software role offer long-term optionality, though the stock's valuation isn't compelling.
NOCBABApALMTOct 17, 2026Boeing Stock Plummets 11% on Production Woes
Neutral Boeing's turnaround hit a snag as production delays and missed delivery targets spook investors, but the long-term story may still hold for patient investors.
BABApAAIRLMTOct 27, 2026Boeing's $10B Cash Goal Meets 737 Delays: Long-Term Buy?
Bullish Boeing's long-term cash targets and defense wins are promising, but near-term production delays and execution risks make it a cautious buy for patient investors.
BABApAOct 28, 2026

